Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections
Clinical trial NCT00921024 · COMPLETED
Trial details
- NCT number
- NCT00921024
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-30
- Primary completion
- 2010-02-25
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.